Product Information
QC CALAMINE PLUS 8%-1% SPRAY is a generic product labeled by Chain Drug Marketing Association Inc, priced at $0.0434 per GM under NDC 83324024241. Its NADAC has been published 93 times since Dec 25, 2024.
Strength
5; 10; 79.5 mg/g; mg/g; mg/g
Manufacturer
Chain Drug Marketing Association IncNDC
83324024241
Classification
Generic
Dosage Form
AEROSOL, SPRAY
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M017On Market Since
6/7/2024
Price Statistics
The NADAC for QC CALAMINE PLUS 8%-1% SPRAY has been published 93 times since Dec 25, 2024, and over the history we have for it it has risen 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0434 per GM |
|---|---|
| All-time high | $0.0441 (Aug 12, 2026) |
| All-time low | $0.0396 (Dec 25, 2024) |
| 52-week high | $0.0441 |
| 52-week low | $0.0430 |
| Median price | $0.0432 |
| Average price | $0.0431 |
| Largest weekly change | +4.3% (Jan 22, 2025) |
| Weeks tracked | 93 |
| Tracking since | Dec 25, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Calamine Plus Pramoxine HCL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calamine Plus Pramoxine HCL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC CALAMINE PLUS 8%-1% SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for QC CALAMINE PLUS 8%-1% SPRAY, manufactured by Chain Drug Marketing Association Inc, is $0.0434 per GM (NDC 83324024241), effective Sep 30, 2026.
How has the price of QC CALAMINE PLUS 8%-1% SPRAY changed over time?
Over the history we have for it, the NADAC for QC CALAMINE PLUS 8%-1% SPRAY has risen 9.5%. It has been tracked across 93 weekly CMS publications since Dec 25, 2024.
What are the highest and lowest recorded NADAC prices for QC CALAMINE PLUS 8%-1% SPRAY?
Since Dec 25, 2024, the NADAC for QC CALAMINE PLUS 8%-1% SPRAY has ranged from a low of $0.0396 (Dec 25, 2024) to a high of $0.0441 (Aug 12, 2026), with a median of $0.0432 per GM.
Are there cheaper alternatives to QC CALAMINE PLUS 8%-1% SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of QC CALAMINE PLUS 8%-1% SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC CALAMINE PLUS 8%-1% SPRAY?
QC CALAMINE PLUS 8%-1% SPRAY (NDC 83324024241) is labeled by Chain Drug Marketing Association Inc, and CMS classifies it as a generic product.